Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial

/PRNewswire/ -- On August 9, 2022, Asieris Pharmaceuticals, a global biopharmaceutical company specializing in the discovery and development of innovative...

Related Keywords

China ,Germany ,Norway ,Oslo ,Hungary ,Netherlands ,Erik Dahl ,Dan Schneider ,David Moskowitz ,Corporate Communications Norway ,Asieris Pharmaceuticals ,Bladder Cancer Company ,National Medical Products Administration ,Oslo Stock Exchange ,Photocure ,